PROCESSED CHEESE PRODUCTS AND PROCESS FOR PRODUCING PROCESSED CHEESE

Processed cheeses with an antihypertensive effect greater than that of conventional cheese are provided in order to obtain a sufficient antihypertensive effect with a small intake. Specifically, processed cheeses with ACE inhibitory activity of 350 units per gram or more are manufactured using natur...

Full description

Saved in:
Bibliographic Details
Main Authors SUZUKI, MASAYUKI, UCHIDA, MASAYUKI, SASE, MANABU, ODA, MUNEHIRO, AIZAWA, SIGERU
Format Patent
LanguageEnglish
French
German
Published 18.06.2014
Subjects
DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE
FOODS OR FOODSTUFFS
HUMAN NECESSITIES
MAKING THEREOF
MILK OR CHEESE SUBSTITUTES
THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online AccessGet full text

Cover

More Information
Summary:Processed cheeses with an antihypertensive effect greater than that of conventional cheese are provided in order to obtain a sufficient antihypertensive effect with a small intake. Specifically, processed cheeses with ACE inhibitory activity of 350 units per gram or more are manufactured using natural cheese such as cheddar cheese produced in New Zealand and Emmental cheese produced in Switzerland with ACE inhibitory activity of 420 units per grams or more. In addition, it is preferable to use low salt or unsalted natural cheese as a raw material, and use potassium salt as molten salt in order to make sodium content 990 mg or less per 100 g of processed cheese.
Bibliography:Application Number: EP20030751340